NEWS
On SYNLAB Nigeria’s Secured Patient Portal, Test Result Delivery’s Safe Alternative
In the bid to address the dangers associated with emailing test results of patients, SYNLAB Nigeria, a member of the SYNLAB Group, with ISO15189 Certification in medical diagnostic services, has come up with a secured patient portal as a safer alternative.
Biztellers reports that SYNLAB is a global diagnostic service provider with presence in 35 countries and over 30 active locations across Nigeria.
According to SYNLAB Nigeria its secured patient portal has numerous advantages such as, restricted access which confers on the portal offers a more controlled environment for accessing test results.
It pointed out that the individualised log-in credentials, drastically reduces the risk of unauthorised access, ensuring that only the intended recipient or the patient, can gain access to the confidential health information.
Still on the features, SYNLAB Nigeria highlighted that it comes with enhanced encryption.
It was gathered that this added layer of security, safeguards the transmission and storage of test results, protecting them from interception by malicious entities.
The SYNLAB Nigeria’s patient portal has a user-friendly interface, which ensures that patients could easily access and intuitive advantage of by registering on the firm’s website.
On the SYNLAB Nigeria’s website, it stated, “They can also contact our customer support on [email protected], WhatsApp 08104607653 or walk into any of our 32 physical locations across the country to register”.
Using the patients’ portal, SYNLAB Nigeria maintains has become necessary because while the convenience of email is unquestionable, the risks associated with transmitting sensitive health information, such as test results, cannot be ignored.
“In an era where individuals access their email on various devices, the potential for unintended exposure is a critical concern.
“By embracing the secured patient portal, patients can avoid these risks, ensuring that they access their test results in a secure and confidential manner.
“Beyond safeguarding sensitive information SYNLAB also seeks to foster a culture of privacy and security in healthcare interactions through the adoption of the patient portal,” it added.
The diagnostic expert noted that unintentional access compromises patients’ privacy with high potential for ethical and legal issues.
To drive the point home, SYNLAB Nigeria share a case scenario, using fictitious names.
It stated, “Sarah, wrestling with the news of an unplanned pregnancy, had decided to confide in her mother when the time was right. However, the delicate balance of trust was disrupted when the mother, Anne, curious about an email notification on the shared family computer, opened a document containing Sarah’s test result.
“The consequences of this unintended intrusion were felt immediately. Instead of the empathetic and supportive conversation that Sarah had hoped for, Anne’s discovery led to a confrontational exchange fuelled by emotions of betrayal and disappointment.”
SYNLAB Nigeria opined that this possible scenario draws attention to the inherent risks associated with delivering sensitive test results via email.
“In an age where digital communication is commonplace, the convenience of email often comes at the cost of privacy, as demonstrated in the story of Anne and Sarah.
“The email, a seemingly innocent means of communication, became a channel for unintended consequences. It allowed Anne access to information that Sarah had not yet shared, and the resulting breach of trust altered the trajectory of their relationship,” it added.
The diagnostic expert, also noted that Anne’s inadvertent access to Sarah’s test results underpinned the potential for unintended recipients to view confidential information.
It is the considered opinion of SYNLAB Nigeria that in the healthcare space, where privacy is paramount, this poses a significant risk to patient confidentiality.
Against this backdrop, SYNLAB Nigeria highlighted other dangers of emailing patients’ diagnostic results, as lack of encryption, saying emails, even those containing sensitive health information, were often transmitted without end-to-end encryption.
The firm also pointed out that absence of encryption exposes the data to potential interception, especially when accessed on public networks, adding that it further jeopardises the confidentiality of the test results.
Expatiating on limited control, it said when an email is delivered, control over who can access the information diminishes using the case point of Anne and Sarah, adding that lack of control over who could view the results led to a breach of Sarah’s privacy and a breakdown in trust.
It also raised the issue of digital sharing, which might be indiscriminate.
SYNLAB Nigeria noted that once someone accesses a digital document, the person could easily share it in one click to anyone else.
“The document alone can be transferred to other platforms and shared or the whole mail can easily be shared. Imagine that Anne, shared Sarah’s result to her father and siblings immediately she saw it,” it pointed out.
SYNLAB Nigeria is the leader in medical diagnostic services and specialty testing in Europe and offers a full range of innovative and reliable medical diagnostics to patients, practising doctors, hospitals and clinics, governments and corporates.
NEWS
Dangote Reveals Date for Much-Awaited Refinery IPO
President of Dangote Industries Limited, Aliko Dangote, has revealed that the much-awaited initial public offering of the Dangote Refinery will open within the next 10 to 12 days.
Dangote disclosed this on Friday while speaking with investors and analysts in Botswana, according to Reuters.
The $20bn Lagos-based refinery is expected to raise about $5bn through the IPO, which could become the largest public offering on the African continent.
ALSO READ: Dangote Investments are Catalysts for Africa’s Economic Growth – AFC
Dangote said the planned listing would support the group’s ambition to further expand the refinery’s capacity.
He said, “Our dream is that we want to make sure we double the capacity of the refinery… which will take us to 1.4 million barrels per day. The IPO will open in the next 10 to 12 days.”
The refinery, currently Africa’s largest, reached its full designed capacity of 650,000 barrels per day in February. It has since pushed production beyond that level, reaching 700,000 barrels per day during testing.
The IPO is part of a broader expansion strategy by the Dangote Group.
Dangote also disclosed that Dangote Cement is expected to secure a secondary listing on the London Stock Exchange, potentially in October, in a move aimed at giving the company access to a wider pool of international investors.
The businessman further confirmed plans to establish a new refinery on Kenya’s coast in partnership with East African governments.
The proposed refinery is expected to supply refined petroleum products to Kenya and neighbouring countries while helping reduce the region’s dependence on fuel imports.
Construction of the Kenyan facility is expected to take up to three years and would represent the Dangote Group’s biggest refining investment outside Nigeria.
The planned refinery IPO and expansion projects underline Dangote Industries’ growing ambitions to strengthen its position in Africa’s energy and industrial sectors.
NEWS
‘Young Nigerians Now Selling Their Kidneys to Survive’ — Atiku Raises Alarm
Former Vice President and African Democratic Congress (ADC) presidential candidate, Atiku Abubakar, has raised the alarm over reports that some young Nigerians are resorting to selling their kidneys for as little as ₦1.7 million to cope with the country’s worsening cost-of-living crisis.
Atiku made the remarks in a statement on Friday, expressing concern that economic hardship was pushing young Nigerians towards increasingly desperate measures simply to survive.
SEE MORE: 2027: ‘Do I Look 80’ — Atiku Fires Back at Critics Over His Age
He described the reported development as “frightening,” stressing that young Nigerians should be using their talents, ideas and creativity to build better lives rather than being forced to consider selling their body organs.
“Young people should be selling dreams, ideas and innovation, not their body organs,” Atiku said.
According to him, the rising cost of essential goods and services, including food, transportation, rent, school fees, medicine and electricity, has placed enormous pressure on Nigerians.
He blamed the economic direction of the administration of President Bola Tinubu for what he described as the worsening hardship confronting citizens.
“In Tinubu’s Nigeria, almost everything required to live with dignity is becoming more expensive by the day: food, transport, rent, school fees, medicine and electricity,” he said.
Atiku said the reported sale of kidneys for as little as ₦1.7 million was evidence that the crisis had moved beyond ordinary economic hardship.
“When young Nigerians begin to see their kidneys as emergency savings, we are no longer talking about ordinary economic hardship. We are talking about desperation at its most frightening,” he added.
The former vice president noted that Nigeria already has laws prohibiting commercial organ sales and organ trafficking.
However, he argued that enforcement alone would not solve the underlying poverty and desperation exposing vulnerable Nigerians to exploitation.
“Laws alone cannot cure the poverty and desperation that make vulnerable young people easy prey for criminal networks,” Atiku said.
He called for economic reforms that would have a direct impact on the living conditions of ordinary Nigerians, including measures to make food and transportation more affordable, improve access to healthcare and create decent employment opportunities.
Atiku further urged the government to pursue policies capable of restoring hope among young Nigerians.
“Our young people should be selling their ideas, talents and innovation to the world and not their kidneys for ₦1.7 million just to survive at home,” he said.
His comments come amid reports of alleged organ sales and a police investigation into an alleged organ-harvesting and human-trafficking operation involving four suspects, including two nephrologists.
Atiku described the situation as a disturbing reflection of what he called the “human cost” of Nigeria’s cost-of-living crisis.
NEWS
Presidency Clears Air on Tinubu’s US Court Case
The Presidency has clarified that President Bola Tinubu is not on trial in the United States, describing the ongoing legal proceedings involving records linked to him as a civil dispute over access to government documents.
The clarification was made by the Special Adviser to the President on Information and Strategy, Bayo Onanuga, amid renewed attention to the case before the United States District Court for the District of Columbia.
According to the Presidency, the matter arose from requests submitted under the US Freedom of Information Act (FOIA) for records relating to Tinubu.
SEE MORE: No Gov’t Reprisal for Criticism — Tinubu Assures Journalists
“For clarity, the matter is a civil records-disclosure dispute under the United States Freedom of Information Act. It is not a criminal case against President Tinubu, nor has the court found him guilty of any criminal wrongdoing,” the Presidency stated.
The government explained that Aaron Greenspan submitted FOIA requests to several US government agencies in 2022, seeking records relating to the President.
After some agencies withheld certain records or declined to confirm or deny their existence, Greenspan commenced Civil Action No. 23-1816 before the US District Court for the District of Columbia in 2023.
The court subsequently permitted President Tinubu to participate in the proceedings as an intervenor.
The Presidency said some of the agencies invoked the “Glomar defence”, a legal position that allows US government agencies, under certain circumstances, to neither confirm nor deny the existence of particular investigative records.
It added that the court subsequently granted summary judgment in favour of the CIA, Executive Office for United States Attorneys, Department of State, Department of the Treasury and Internal Revenue Service, effectively removing them from the proceedings.
However, aspects of the case involving the Federal Bureau of Investigation and the Drug Enforcement Administration remained subject to further consideration.
The Presidency further disclosed that the FBI and DEA had produced 399 pages of records in compliance with court orders, although portions of the documents were redacted under exemptions provided by US law.
According to the government, the plaintiff challenged the agencies’ decision to redact parts of the documents and sought their release without the redactions.
The FBI and DEA, through the US Department of Justice, opposed the request, citing legal protections covering certain categories of information.
The Presidency said some of the records relate to grand jury proceedings, which are protected from public disclosure under US law.
It also cited protections covering information connected to certain court orders authorising pen registers or trap-and-trace devices, as well as documents protected by attorney-client and attorney-work-product privileges.
The Presidency’s clarification comes amid heightened political debate ahead of Nigeria’s 2027 general elections, with opposition figures continuing to scrutinise the President’s past and administration.
The government, however, maintained that the US proceedings should not be misrepresented as a criminal trial against Tinubu, stressing that the case concerns the disclosure and withholding of government records.





